Hi Timjohn,
Thanks for the reply.
I was aware it was a new product, but my understanding was that it was hoped it would take sales from an existing product due to its improved performance characteristics over the existing similar product.
Happy to be corrected though.
Cheers
Phil
- Forums
- ASX - By Stock
- ADO
- roche and its spare money
roche and its spare money, page-45
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(3.67%) |
Mkt cap ! $52.28M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.1¢ | $7.812K | 349.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 828094 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 1102151 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 828094 | 0.021 |
7 | 1691000 | 0.020 |
2 | 782500 | 0.019 |
7 | 2041613 | 0.018 |
5 | 1374748 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 1102151 | 4 |
0.023 | 22000 | 1 |
0.025 | 40000 | 1 |
0.026 | 76000 | 2 |
0.027 | 22000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online